NCT00414232 Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy Status COMPLETED Phase N/A
NCT00411450 Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment Status COMPLETED Phase PHASE2
NCT00394615 Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA Status TERMINATED Phase NA
NCT00353457 Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma Status TERMINATED Phase PHASE2
NCT00346099 Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum Status WITHDRAWN Phase PHASE2
NCT00337389 Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. Status UNKNOWN Phase PHASE3
NCT00335504 Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia Status COMPLETED Phase PHASE2
NCT00308516 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer Status COMPLETED Phase PHASE2
NCT00307736 Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00297141 Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma Status COMPLETED Phase PHASE2
NCT00297128 Preoperative Chemoradiation With Capecitabine and Cetuximab Status COMPLETED Phase PHASE2
NCT00254683 Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer Status UNKNOWN Phase PHASE2
NCT00254436 A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients Status TERMINATED Phase PHASE3
NCT00250835 Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer Status TERMINATED Phase PHASE2
NCT00235898 Clinical Trial in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2